ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B

GlaxoSmithKline PLC Director/PDMR Shareholding (2797D)

25/04/2017 1:45pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 2797D

GlaxoSmithKline PLC

25 April 2017

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr N Hirons 
===  ========================  =============================================== 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 13 
                                April 2017. 
===  ========================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $41.1461   19.456 
                                ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-04-24 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr B McNamara 
===  ========================  =============================================== 
 b)   Position/status          CEO, Consumer Healthcare 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 13 
                                April 2017. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $41.1461   230.514 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-04-24 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================= 
 a)   Name                     Mr D E Troy 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 13 
                                April 2017. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                 ---------  ---------- 
                                  $41.1461   1,810.730 
                                 ---------  ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2017-04-24 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLELFLDZFZBBX

(END) Dow Jones Newswires

April 25, 2017 08:45 ET (12:45 GMT)

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock